"Efficacy and safety of panitumumab alone or in association with radiotherapy in unresectable cutaneous squamous-cell carcinoma".

Date publication

avril 2020

Journal

Journal of the European Academy of Dermatology and Venereology : JEADV

Auteurs

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32294281

Résumé

The prognosis of unresectable cutaneous squamous-cell carcinomas is very poor.

Mots clés

efficacy and safety, panitumumab, unresectable cutaneous squamous cell-carcinoma

Référence

J Eur Acad Dermatol Venereol. 2020 Apr 15;: